NLRP3 and Parkinson disease: An experimental model of PD induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) confirmed that excessive activation of the microglial NLRP3 inflammasome plays a critical role in the pathological mechanisms of PD [58].